Name | Walmart Pharmacy 10-2840 |
---|---|
Organization Name | Wal-mart Stores East Lp |
Location | 11 Glynn Plz, Brunswick, Georgia 31520 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (912) 602-6146 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Amgen today announced that it will present data from several key Nplate (romiplostim) studies at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 4-7, 2010, in Orlando, Fla.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Bacteria feel pressures to evolve antibiotic resistance and other new abilities in response to a changing environment, and they react by 'stealing' genetic information from other better-adapted types of bacteria, according to research published in Nature Genetics.
› Verified 6 days ago
NPI Number | 1205230562 |
Organization Name | WAL-MART STORES EAST LP |
Doing Business As | WALMART PHARMACY 10-2840 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 11 Glynn Plz, Brunswick, GA 31520 |
Phone Number | 912-602-6146 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Amgen today announced that it will present data from several key Nplate (romiplostim) studies at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 4-7, 2010, in Orlando, Fla.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Bacteria feel pressures to evolve antibiotic resistance and other new abilities in response to a changing environment, and they react by 'stealing' genetic information from other better-adapted types of bacteria, according to research published in Nature Genetics.
› Verified 6 days ago
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Amgen today announced that it will present data from several key Nplate (romiplostim) studies at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 4-7, 2010, in Orlando, Fla.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Bacteria feel pressures to evolve antibiotic resistance and other new abilities in response to a changing environment, and they react by 'stealing' genetic information from other better-adapted types of bacteria, according to research published in Nature Genetics.
› Verified 6 days ago
Jones Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3000 Altama Ave, Brunswick, Georgia 31520 Phone: (912) 265-7500 | |
American Home Patient, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 208 Scranton Connector, Brunswick, Georgia 31525 Phone: (912) 264-5333 | |
Brunswick Orthotics & Prosthetics I Type: Prosthetic/Orthotic Supplier Location: 3501 Altama Ave, Brunswick, Georgia 31520 Phone: (912) 261-8117 | |
Coastal Pharmacare Inc Type: DME Supplier - Customized Equipment Location: 220 Blythe Island Connector, Brunswick, Georgia 31520 Phone: (912) 261-7190 | |
Emri Comer Od Pc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 40 Professioinal Dr, Brunswick, Georgia 31520 Phone: (912) 261-0788 |